Menaquinone Biosynthesis Mechanisms and Antimicrobial Targets

Menaquinone, or vitamin K2, is a lipid-soluble electron carrier central to bacterial respiratory chains, particularly in Gram-positive and anaerobic Gram-negative pathogens. Its biosynthesis proceeds through a conserved pathway that begins with chorismate conversion to isochorismate, followed by a thiamine diphosphate–dependent conjugation catalysed by MenD to form SEPHCHC, subsequent cyclisation and oxidation by MenC and MenB to yield 1,4-dihydroxy-2-naphthoic acid (DHNA). Prenylation by MenA attaches the polyprenyl chain, while methyltransferase and reductase enzymes finalise the demethylmenaquinone to mature menaquinone. Each enzymatic step presents an opportunity for antimicrobial intervention, as the pathway is absent in humans and essential for bacterial energy metabolism and virulence. Recent structural and mechanistic studies have illuminated the active-site architecture of key enzymes and unveiled feedback control by downstream metabolites, guiding the design of specific inhibitors. Targeting prenyltransferase activity, allosteric regulatory sites or cofactor interactions has yielded promising lead compounds that arrest bacterial respiration, attenuate biofilm formation and modulate host immune responses. Continued exploration of pathway regulation, enzyme dynamics and inhibitor specificity holds significant potential for next-generation antibiotics against resistant bacterial strains.

Research from Nature Portfolio

Long-chain synthetic compounds have been designed to inhibit MenA in methicillin-resistant Staphylococcus aureus, demonstrating bactericidal and biofilm-suppressing activities at low micromolar concentrations. Supplementation with menaquinone rescued bacterial growth, confirming on-target inhibition. Intriguingly, these molecules also modulate macrophage cytokine release by reducing pro-inflammatory mediators and enhancing interleukin-1β, suggesting dual antimicrobial and immunomodulatory effects that may bolster host defences.

Menaquinone Biosynthesis Mechanisms and Antimicrobial Targets publication trend

The graph below shows the total number of articles in menaquinone biosynthesis mechanisms and antimicrobial targets across all publications each year (not limited to Nature Index journals).

Technical terms

Menaquinone: A bacterial electron carrier (vitamin K2) essential for respiratory chain function.

MenD: A thiamine diphosphate–dependent enzyme catalysing the first committed step in menaquinone biosynthesis.

1,4-Dihydroxy-2-naphthoic acid (DHNA): A key intermediate metabolite that can regulate pathway flux by feedback inhibition.

MenA: An isoprenyltransferase that attaches the hydrophobic prenyl chain to DHNA, anchoring menaquinone in the bacterial membrane.

References

1. Allosteric inhibition of Staphylococcus aureus MenD by 1,4-dihydroxy naphthoic acid: a feedback inhibition mechanism of the menaquinone biosynthesis pathway. Philosophical Transactions of the Royal Society B Biological Sciences (2023).
2. Enzymatic Stetter Reaction: Computational Study of the Reaction Mechanism of MenD. ACS Catalysis (2021).
3. Menaquinone biosynthesis inhibition: a review of advancements toward a new antibiotic mechanism. RSC Advances (2018).
4. Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm. Scientific Reports (2017).